Cathay Biotech Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 505.45 million compared to CNY 661.27 million a year ago. Revenue was CNY 505.45 million compared to CNY 661.27 million a year ago.

Net income was CNY 57.44 million compared to CNY 174.55 million a year ago. Basic earnings per share from continuing operations was CNY 0.1 compared to CNY 0.3 a year ago. Diluted earnings per share from continuing operations was CNY 0.1 compared to CNY 0.3 a year ago.